Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Motion Sickness Drugs Market: By Product: Anticholinergics, Antihistamines; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand, EMR’s Key Indicators for Price; Competitive Landscape; Industry Events and Developments
Global Motion Sickness Drugs Market Outlook
The global motion sickness drugs market is projected to grow at a CAGR of 4.2% over the forecast period of 2022-2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global motion sickness drugs market is being driven by the growing use of generic drugs as both over the counter (OTC) and prescription drugs. OTC drugs do not require a professional medical prescription, which has made it more accessible and affordable for consumers. OTC drugs give patients the option for self-medication to relieve mild disease-related symptoms. There are a number of antihistamines used as OTC drugs. This will increase the acceptance of antihistamines to stop motion sickness symptoms, which will further improve the demand for motion sickness drugs. Thus, the availability of over-the-counter (OTC) drugs, along with the advent of nauseogenic information technology, are the factors driving the industry further.
Market Segmentation
The global motion sickness drugs market can be broadly categorised based on segments like products and regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
- Products:
- Anticholinergics
- Antihistamines
The EMR report looks into the regional motion sickness drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
A better understanding of neurological mechanisms associated with motion sickness has been provided by techniques such as traditional neurophysiology, pathway mapping, and magnetic resonance imaging (MRI). Nauseogenic IT has emerged as one of the most popular methods of understanding the neurophysiology and brain parts responsible for this disease. Using nauseogenic vehicles allows to examine postural stability of a person and identifies neural or sensory-motor mechanisms that help to achieve positive body stability. Nauseogenic information technology’s critical knowledge will help develop and improve motion sickness drugs, which will aid the industry growth. Hence, the advancement in nauseogenic information technology coupled with the easy availability and accessibility of OTC drugs are the key factors, which are expected to have a positive impact on the industry growth over the forecast period. However, side effects associated with motion sickness drugs can hamper industry growth over the forecast period.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global motion sickness drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Baxter International Inc. (NYSE: BAX)
- GlaxoSmithKline Plc
- Johnson & Johnson Services Inc.
- Pfizer Inc.
- Prestige Consumer Healthcare Inc.
- Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region |
| Breakup by Product | Anticholinergics, Antihistamines |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Baxter International Inc., GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Pfizer Inc., Prestige Consumer Healthcare Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Motion Sickness Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Motion Sickness Drugs Historical Market (2017-2021)
8.3 Global Motion Sickness Drugs Market Forecast (2022-2027)
8.4 Global Motion Sickness Drugs Market by Product
8.4.1 Anticholinergics
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Antihistamines
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.5 Global Motion Sickness Drugs Market by Region
8.5.1 Market Share
8.5.1.1 North America
8.5.1.2 Europe
8.5.1.3 Asia Pacific
8.5.1.4 Latin America
8.5.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Baxter International Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 GlaxoSmithKline PLC
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Johnson & Johnson Services Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Pfizer Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Prestige Consumer Healthcare Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Motion Sickness Drugs Market: Key Industry Highlights, 2016 and 2026
2. Global Motion Sickness Drugs Historical Market: Breakup by Product (USD Million), 2017-2021
3. Global Motion Sickness Drugs Market Forecast: Breakup by Product (USD Million), 2022-2027
4. Global Motion Sickness Drugs Historical Market: Breakup by Region (USD Million), 2017-2021
5. Global Motion Sickness Drugs Market Forecast: Breakup by Region (USD Million), 2022-2027
6. North America Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
7. North America Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
8. Europe Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
9. Europe Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Asia Pacific Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
11. Asia Pacific Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Latin America Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
13. Latin America Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Middle East and Africa Motion Sickness Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
15. Middle East and Africa Motion Sickness Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Global Motion Sickness Drugs Market Structure
Key Questions Answered in the Report
The global motion sickness drugs market is projected to grow at a CAGR of 4.2% between 2021 and 2026.
The major drivers of the industry, such as the growing sales of generic drugs, particularly OTC (over the counter) drugs, increasing population, increasing health awareness, and the growing research and development activities, are expected to aid the market growth.
Advancements in nauseogenic information technology is the key market trend guiding the growth of the industry.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Anticholinergics and antihistamines are the leading products of motion sickness drugs in the market.
The major players in the industry are Baxter International Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Pfizer Inc., and Prestige Consumer Healthcare Inc., among others.
Analyst Review
The global motion sickness drugs market is being driven by the growing demand for OTC (over the counter) drugs and increased investments by the key players in R&D activities. Aided by the growing popularity of nauseogenic information technology, the market is expected to witness a healthy growth in the forecast period of 2022-2027, growing at a CAGR of 4.2%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on products, the industry can be segmented into anticholinergics and antihistamines. The major regional markets for motion sickness drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Baxter International Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Pfizer Inc., Prestige Consumer Healthcare Inc., and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global companion animal vaccine market is expected to grow at a CAGR of 6.2% during the period 2022-2027. The market is expected to be driven by the growing rate of adoption of companion animals, ...
The global cardiometabolic disease market attained a value of USD 111 billion in 2021, driven by the rise in various diseases, such as diabetes, high cholesterol, and cardiac disorders. Aided by the r...
The global astaxanthin market was driven by the high demand for nutraceuticals in the historical period. Aided by the growing number of health-conscious individuals and growing preference for dietary ...
The global inhaled nitric oxide market attained a value of USD 684.6 million in 2021, driven by the rising cases of breathing problems among the geriatrics and new born babies. Aided by the growing pa...
The global superdisintegrants market attained a value of nearly USD 368.1 million in 2021, driven by the rising demand for mouth-dissolving films. Aided by the growing technological advancements, the ...
NEWSLETTER